Jeeva Sankar

Jeeva is working as an Additional Professor in the Division of Neonatology, Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), New Delhi. Earlier, he worked as a Medical Officer in the Department of Child and Adolescent Health and Development, World Health Organization (WHO), Geneva (2010).

An avid researcher, Jeeva has published more than 100 original articles in reputed journals, including The Lancet, BMJ, and Lancet Global Health. His name features in the global database of the top 2% of scientists across all scientific fields based on the ranking of a composite indicator (using the data for citations in a single calendar year, 2021). His primary area of research interest is neonatal sepsis. He coordinated the multicenter study on sepsis involving around 15000 neonates in four tertiary care hospitals of Delhi (DeNIS collaboration). He is the Principal Investigator of two ongoing multi-site studies on neonatal sepsis – a multi-institutional research program on understanding the biology of neonatal sepsis (funded by the Department of Biotechnology, Government of India) and another on the epidemiology of sepsis in level-2 units in the district hospitals of India (funded by the Bill & Melinda Gates Foundation). He has conducted around 40 systematic reviews and synthesized the evidence for eight global WHO guidelines, including “Postnatal care of neonates and mothers.”

Jeeva is one of the global and national collaborators of the Global Burden of Diseases (GBD), the Institute for Health Metrics and Evaluation, Seattle. He is also a member of the Guideline Development Group (GDG) of the WHO, Geneva, in ‘Maternal and Perinatal Health’ and a member of the ‘Technical Advisory Group (TAG)’ of the WHO ACTION-III trial on the use of low-dose antenatal steroids in women with preterm labor.